These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6961839)

  • 1. Differences in growth regulation of normal and tumor cells.
    Pardee AB; Campisi J; Croy RG
    Ann N Y Acad Sci; 1982 Dec; 397():121-9. PubMed ID: 6961839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of protein degradation on cellular growth characteristics.
    Baxter GC; Stanners CP
    J Cell Physiol; 1978 Aug; 96(2):139-45. PubMed ID: 670299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells.
    Campisi J; Medrano EE; Morreo G; Pardee AB
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):436-40. PubMed ID: 6952194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest.
    Medrano EE; Pardee AB
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4123-6. PubMed ID: 6933461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth.
    Rossow PW; Riddle VG; Pardee AB
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4446-50. PubMed ID: 291975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth control of normal and transformed cells.
    Riddle VG; Pardee AB; Rossow PW
    J Supramol Struct; 1979; 11(4):529-38. PubMed ID: 397367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth arrest states of RNA virus- and chemically transformed mouse cells.
    Riddle VG; Lehtomaki DM
    Cancer Res; 1981 May; 41(5):1778-83. PubMed ID: 6260351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein metabolism during growth of Vero Cells.
    Lee GT; Engelhardt DL
    J Cell Physiol; 1977 Aug; 92(2):293-301. PubMed ID: 881437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of factors released from the tumor-transformed cells on DNA synthesis, mitosis, and cellular enlargement in 3T3 fibroblasts.
    Dafgård E; Engström W; Larsson O; Zetterberg A
    J Cell Physiol; 1987 Aug; 132(2):295-302. PubMed ID: 3040778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular plasminogen activator activity in growing and quiescent cells.
    Loskutoff DJ; Paul D
    J Cell Physiol; 1978 Oct; 97(1):9-16. PubMed ID: 213444
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous protein synthesis is required to maintain the probability of entry into S phase.
    Brooks RF
    Cell; 1977 Sep; 12(1):311-7. PubMed ID: 902318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein synthesis and heat protection: histidinol-resistant mutant cell lines.
    Lee YJ; Hou ZZ; Kim D; al-Saadi A; Corry PM
    J Cell Physiol; 1991 Dec; 149(3):396-402. PubMed ID: 1744171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
    Mizumoto K; Rothman RJ; Farber JL
    Mol Pharmacol; 1994 Nov; 46(5):890-5. PubMed ID: 7969076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
    Brandes LJ; LaBella FS; Warrington RC
    J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA; Sheridan KM
    J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the rates of aerobic glycolysis and glucose transport, unrelated to neoplastic transformation, in a series of BALB 3T3-derived cell lines.
    Peterkofsky B; Prather W
    Cancer Res; 1982 May; 42(5):1809-16. PubMed ID: 6802484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The uncoupling of macromolecular synthesis from cell division in SV3T3 cells by glucocorticoids: the imposition of a G2 block.
    Das HR; Lavin M; Sicuso A; Young DV
    J Cell Physiol; 1983 Nov; 117(2):241-8. PubMed ID: 6313705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of a commitment program for mitosis in early G1 in tumour cells.
    Larsson O; Zetterberg A
    Cell Prolif; 1995 Jan; 28(1):33-43. PubMed ID: 7833384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of protein synthesis as a mechanism of neoplastic transformation.
    Rosenwald IB
    Bioessays; 1996 Mar; 18(3):243-50. PubMed ID: 8867739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.